Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 5, 2010, Pages 1024-1031

  Tamaro, Ilaria ^a   Aprile, Silvio ^a   Giovenzana, Giovanni B ^a   Grosa, Giorgio ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Alizapride; Degradation products; HPLC UV; Stability indicating

Indexed keywords

6 METHOXY 1H BENZOTRIAZOLE 5 CARBOXYLIC ACID; 6 METHOXY 1H BENZOTRIAZOLE 5 CARBOXYLIC ACID (1 ALLYL 1 OXYPYRROLIDIN 2 YLMETHYL)AMIDE; ALIZAPRIDE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG OXIDATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANTIEMETICS; CARBOXYLIC ACIDS; CATALYSIS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; OXIDATION-REDUCTION; OXIDES; PYRROLIDINES; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TECHNOLOGY, PHARMACEUTICAL;

EID: 73049118201     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.10.026     Document Type: Article

References (13)

1. Joss R.A., Galeazzi R.L., Bischoff A.K., and Brunner K.W. Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy. Eur. J. Clin. Pharmacol. 27 (1985) 721-725
2. Bleiberg H., Gerard B., Dalesio O., Crespeigne N., and Rozencweig M. Activity of a new antiemetic agent: alizapride. Cancer Chemother. Pharmacol. 22 (1988) 316-320
3. Tracqui A., Kintz P., and Mangin P. Systematic toxicological analysis using HPLC/DAD. J. Forensic Sci. 40 (1995) 254-262
4. De Jong A.P., Wittebrood A.J., Du Chatinier W.M., and Bron J. Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction. J. Chromatogr. 419 (1987) 233-242
5. Bron J., Wittebrood A.J., De Jong A.P., and Du Chatinier W.M. Chromatography of substituted benzamides. Isocratic high-performance-liquid chromatographic identification method of eight compounds of therapeutic interest. J. Pharm. Belg. 42 (1987) 47-52
6. Coulais Y., Campistron G., Caillard C., and Houin G. Quantitative determination of alizapride in human plasma by high-performance liquid chromatography. J. Chromatogr. 374 (1986) 425-429
7. Houin G., Bree F., Lerumeur N., and Tillement J.P. High-performance liquid chromatographic determination of alizapride, a new antiemetic compound, and its application to a dose-dependent pharmacokinetic study. J. Pharm. Sci. 72 (1983) 71-74
8. Demore B., Raffy F., Commun N., Vigneron J., Perrin A., Hoffman M.A., and Hoffman M. Study on the stability of two antiemetic benzamides in PVC pouches with 0.9% sodium chloride or 5% glucose over a five month period. J. Pharm. Clin. 14 (1995) 178-179
9. Hoffmann H., and Jacobi S. Hydrolysis of the antiemetic drug alizapride. Arzneimittelforschung 34 (1984) 1714-1715
10. Stability Testing of New Drug Substances and Products, ICH Harmonised Tripartite Guidelines, 1995, pp. 1-14.
11. Grosa G., Del Grosso E., Russo R., and Allegrone G. Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup. J. Pharm. Biomed. Anal. 41 (2006) 798-803
12. Validation of Analytical Procedures: Text and Methodology, ICH Harmonised Tripartite Guidelines, 2005, pp. 1-13.
13. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Reviewer Guidance, Validation of Chromatographic Methods (November 1994), FDA, Rockville, MD